LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 62

Search options

  1. Article ; Online: T-bet

    Khan, Saad / Winer, Daniel A

    Trends in immunology

    2022  Volume 43, Issue 11, Page(s) 855–857

    Abstract: B cells are associated with the development of obesity-associated metabolic disease. Recently, Hägglöf, Vanz, et al. identified a novel obesity-related subset of B cells that are demarcated by the transcription factor T-bet and their pathogenic ability ... ...

    Abstract B cells are associated with the development of obesity-associated metabolic disease. Recently, Hägglöf, Vanz, et al. identified a novel obesity-related subset of B cells that are demarcated by the transcription factor T-bet and their pathogenic ability to worsen metabolic disease outcomes.
    MeSH term(s) Humans ; T-Box Domain Proteins/metabolism ; B-Lymphocytes/metabolism ; Obesity ; Metabolic Diseases/metabolism
    Chemical Substances T-Box Domain Proteins
    Language English
    Publishing date 2022-10-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 2036831-8
    ISSN 1471-4981 ; 1471-4906
    ISSN (online) 1471-4981
    ISSN 1471-4906
    DOI 10.1016/j.it.2022.09.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Chronic inflammation and the hallmarks of aging.

    Baechle, Jordan J / Chen, Nan / Makhijani, Priya / Winer, Shawn / Furman, David / Winer, Daniel A

    Molecular metabolism

    2023  Volume 74, Page(s) 101755

    Abstract: Background: Recently, the hallmarks of aging were updated to include dysbiosis, disabled macroautophagy, and chronic inflammation. In particular, the low-grade chronic inflammation during aging, without overt infection, is defined as "inflammaging," ... ...

    Abstract Background: Recently, the hallmarks of aging were updated to include dysbiosis, disabled macroautophagy, and chronic inflammation. In particular, the low-grade chronic inflammation during aging, without overt infection, is defined as "inflammaging," which is associated with increased morbidity and mortality in the aging population. Emerging evidence suggests a bidirectional and cyclical relationship between chronic inflammation and the development of age-related conditions, such as cardiovascular diseases, neurodegeneration, cancer, and frailty. How the crosstalk between chronic inflammation and other hallmarks of aging underlies biological mechanisms of aging and age-related disease is thus of particular interest to the current geroscience research.
    Scope of review: This review integrates the cellular and molecular mechanisms of age-associated chronic inflammation with the other eleven hallmarks of aging. Extra discussion is dedicated to the hallmark of "altered nutrient sensing," given the scope of Molecular Metabolism. The deregulation of hallmark processes during aging disrupts the delicate balance between pro-inflammatory and anti-inflammatory signaling, leading to a persistent inflammatory state. The resultant chronic inflammation, in turn, further aggravates the dysfunction of each hallmark, thereby driving the progression of aging and age-related diseases.
    Main conclusions: The crosstalk between chronic inflammation and other hallmarks of aging results in a vicious cycle that exacerbates the decline in cellular functions and promotes aging. Understanding this complex interplay will provide new insights into the mechanisms of aging and the development of potential anti-aging interventions. Given their interconnectedness and ability to accentuate the primary elements of aging, drivers of chronic inflammation may be an ideal target with high translational potential to address the pathological conditions associated with aging.
    MeSH term(s) Humans ; Aged ; Inflammation ; Anti-Inflammatory Agents ; Cardiovascular Diseases
    Chemical Substances Anti-Inflammatory Agents
    Language English
    Publishing date 2023-06-15
    Publishing country Germany
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2708735-9
    ISSN 2212-8778 ; 2212-8778
    ISSN (online) 2212-8778
    ISSN 2212-8778
    DOI 10.1016/j.molmet.2023.101755
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The intestinal immune system and gut barrier function in obesity and ageing

    Shemtov, Sarah J. / Emani, Rohini / Bielska, Olga / Covarrubias, Anthony J. / Verdin, Eric / Andersen, Julie K. / Winer, Daniel A.

    The FEBS Journal. 2023 Sept., v. 290, no. 17 p.4163-4186

    2023  

    Abstract: Obesity and ageing predispose to numerous, yet overlapping chronic diseases. For example, metabolic abnormalities, including insulin resistance (IR) and type 2 diabetes (T2D) are important causes of morbidity and mortality. Low‐grade chronic inflammation ...

    Abstract Obesity and ageing predispose to numerous, yet overlapping chronic diseases. For example, metabolic abnormalities, including insulin resistance (IR) and type 2 diabetes (T2D) are important causes of morbidity and mortality. Low‐grade chronic inflammation of tissues, such as the liver, visceral adipose tissue and neurological tissues, is considered a significant contributor to these chronic diseases. Thus, it is becoming increasingly important to understand what drives this inflammation in affected tissues. Recent evidence, especially in the context of obesity, suggests that the intestine plays an important role as the gatekeeper of inflammatory stimuli that ultimately fuels low‐grade chronic tissue inflammation. In addition to metabolic diseases, abnormalities in the intestinal mucosal barrier have been linked to a range of other chronic inflammatory conditions, such as neurodegeneration and ageing. The flow of inflammatory stimuli from the gut is in part controlled by local immunological inputs impacting the intestinal barrier. Here, we will review the impact of obesity and ageing on the intestinal immune system and its downstream consequences on gut barrier function, which is strongly implicated in the pathogenesis of obesity and age‐related diseases. In particular, we will discuss the effects of age‐related intestinal dysfunction on neurodegenerative diseases.
    Keywords absorption barrier ; adipose tissue ; immune system ; inflammation ; insulin resistance ; intestines ; liver ; mortality ; neurodegenerative diseases ; noninsulin-dependent diabetes mellitus ; obesity ; pathogenesis
    Language English
    Dates of publication 2023-09
    Size p. 4163-4186.
    Publishing place John Wiley & Sons, Ltd
    Document type Article ; Online
    Note REVIEW
    ZDB-ID 2173655-8
    ISSN 1742-4658 ; 1742-464X
    ISSN (online) 1742-4658
    ISSN 1742-464X
    DOI 10.1111/febs.16558
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Emerging concepts in intestinal immune control of obesity-related metabolic disease.

    Khan, Saad / Luck, Helen / Winer, Shawn / Winer, Daniel A

    Nature communications

    2021  Volume 12, Issue 1, Page(s) 2598

    Abstract: The intestinal immune system is an important modulator of glucose homeostasis and obesity-associated insulin resistance. Dietary factors, the intestinal microbiota and their metabolites shape intestinal immunity during obesity. The intestinal immune ... ...

    Abstract The intestinal immune system is an important modulator of glucose homeostasis and obesity-associated insulin resistance. Dietary factors, the intestinal microbiota and their metabolites shape intestinal immunity during obesity. The intestinal immune system in turn affects processes such as intestinal permeability, immune cell trafficking, and intestinal hormone availability, impacting systemic insulin resistance. Understanding these pathways might identify mechanisms underlying treatments for insulin resistance, such as metformin and bariatric surgery, or aid in developing new therapies and vaccination approaches. Here, we highlight evolving concepts centered on intestinal immunity, diet, and the microbiota to provide a working model of obesity-related metabolic disease.
    MeSH term(s) Animals ; B-Lymphocytes/immunology ; Cytokines/metabolism ; Diet Therapy ; Gastrointestinal Microbiome/immunology ; Humans ; Immune System/cytology ; Immune System/metabolism ; Inflammation/immunology ; Inflammation/metabolism ; Insulin Resistance/immunology ; Metabolic Diseases/immunology ; Metabolic Diseases/metabolism ; Metabolic Diseases/microbiology ; Metabolic Diseases/therapy ; Obesity/diet therapy ; Obesity/immunology ; Obesity/metabolism ; Obesity/therapy ; T-Lymphocytes/immunology
    Chemical Substances Cytokines
    Language English
    Publishing date 2021-05-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-021-22727-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Mechanosensing in macrophages and dendritic cells in steady-state and disease.

    Lee, Megan / Du, Huixun / Winer, Daniel A / Clemente-Casares, Xavier / Tsai, Sue

    Frontiers in cell and developmental biology

    2022  Volume 10, Page(s) 1044729

    Abstract: Macrophages and dendritic cells are myeloid cells that play critical roles in immune responses. Macrophages help to maintain homeostasis through tissue regeneration and the clearance of dead cells, but also mediate inflammatory processes against invading ...

    Abstract Macrophages and dendritic cells are myeloid cells that play critical roles in immune responses. Macrophages help to maintain homeostasis through tissue regeneration and the clearance of dead cells, but also mediate inflammatory processes against invading pathogens. As the most potent antigen-presenting cells, dendritic cells are important in connecting innate to adaptive immune responses
    Language English
    Publishing date 2022-11-17
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2737824-X
    ISSN 2296-634X
    ISSN 2296-634X
    DOI 10.3389/fcell.2022.1044729
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Regulation of the immune system by the insulin receptor in health and disease.

    Makhijani, Priya / Basso, Paulo José / Chan, Yi Tao / Chen, Nan / Baechle, Jordan / Khan, Saad / Furman, David / Tsai, Sue / Winer, Daniel A

    Frontiers in endocrinology

    2023  Volume 14, Page(s) 1128622

    Abstract: The signaling pathways downstream of the insulin receptor (InsR) are some of the most evolutionarily conserved pathways that regulate organism longevity and metabolism. InsR signaling is well characterized in metabolic tissues, such as liver, muscle, and ...

    Abstract The signaling pathways downstream of the insulin receptor (InsR) are some of the most evolutionarily conserved pathways that regulate organism longevity and metabolism. InsR signaling is well characterized in metabolic tissues, such as liver, muscle, and fat, actively orchestrating cellular processes, including growth, survival, and nutrient metabolism. However, cells of the immune system also express the InsR and downstream signaling machinery, and there is increasing appreciation for the involvement of InsR signaling in shaping the immune response. Here, we summarize current understanding of InsR signaling pathways in different immune cell subsets and their impact on cellular metabolism, differentiation, and effector versus regulatory function. We also discuss mechanistic links between altered InsR signaling and immune dysfunction in various disease settings and conditions, with a focus on age related conditions, such as type 2 diabetes, cancer and infection vulnerability.
    MeSH term(s) Humans ; Receptor, Insulin/metabolism ; Insulin/metabolism ; Diabetes Mellitus, Type 2/metabolism ; Signal Transduction ; Immune System/metabolism
    Chemical Substances Receptor, Insulin (EC 2.7.10.1) ; Insulin
    Language English
    Publishing date 2023-03-13
    Publishing country Switzerland
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2023.1128622
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Gut T Cells Feast on GLP-1 to Modulate Cardiometabolic Disease.

    Tsai, Sue / Winer, Shawn / Winer, Daniel A

    Cell metabolism

    2019  Volume 29, Issue 4, Page(s) 787–789

    Abstract: Glucagon-like peptide-1 (GLP-1) is an enteroendocrine hormone that controls insulin secretion, intestinal function, and food intake. Recently in Nature, He et al. (2019) reported that gut intraepithelial T cells regulate GLP-1 bioavailability by ... ...

    Abstract Glucagon-like peptide-1 (GLP-1) is an enteroendocrine hormone that controls insulin secretion, intestinal function, and food intake. Recently in Nature, He et al. (2019) reported that gut intraepithelial T cells regulate GLP-1 bioavailability by capturing it on GLP-1 receptors and impacting L-cell numbers. This study delineates a novel endocrine-immune axis through which intestinal immune cells regulate whole-body metabolism.
    MeSH term(s) Cardiovascular Diseases ; Enteroendocrine Cells ; Glucagon-Like Peptide 1 ; Humans ; Intestines ; Intraepithelial Lymphocytes ; Male
    Chemical Substances Glucagon-Like Peptide 1 (89750-14-1)
    Language English
    Publishing date 2019-04-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2176834-1
    ISSN 1932-7420 ; 1550-4131
    ISSN (online) 1932-7420
    ISSN 1550-4131
    DOI 10.1016/j.cmet.2019.03.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Adipose Tissue B Cells Come of Age: The AABs of Fat Inflammation.

    Khan, Saad / Tsai, Sue / Winer, Daniel A

    Cell metabolism

    2019  Volume 30, Issue 6, Page(s) 997–999

    Abstract: For nearly a decade, B cells residing locally within the adipose tissue have been linked to the control of metabolic homeostasis. In this issue, Camell et al. (2019) report an expansion of a unique age-associated B cell population in the visceral adipose ...

    Abstract For nearly a decade, B cells residing locally within the adipose tissue have been linked to the control of metabolic homeostasis. In this issue, Camell et al. (2019) report an expansion of a unique age-associated B cell population in the visceral adipose tissue that regulates insulin resistance and adipose dysfunction during aging.
    MeSH term(s) Adipose Tissue ; Aging ; B-Lymphocytes ; Homeostasis ; Humans ; Inflammasomes ; Inflammation ; Insulin Resistance ; NLR Family, Pyrin Domain-Containing 3 Protein
    Chemical Substances Inflammasomes ; NLR Family, Pyrin Domain-Containing 3 Protein ; NLRP3 protein, human
    Language English
    Publishing date 2019-12-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2176834-1
    ISSN 1932-7420 ; 1550-4131
    ISSN (online) 1932-7420
    ISSN 1550-4131
    DOI 10.1016/j.cmet.2019.11.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Cholesterol accumulation impairs HIF-1α-dependent immunometabolic reprogramming of LPS-stimulated macrophages by upregulating the NRF2 pathway.

    Ting, Kenneth K Y / Yu, Pei / Dow, Riley / Ibrahim, Hisham / Karim, Saraf / Polenz, Chanele K / Winer, Daniel A / Woo, Minna / Jongstra-Bilen, Jenny / Cybulsky, Myron I

    Scientific reports

    2024  Volume 14, Issue 1, Page(s) 11162

    Abstract: Lipid accumulation in macrophages (Mφs) is a hallmark of atherosclerosis. Yet, how lipid loading modulates Mφ inflammatory responses remains unclear. We endeavored to gain mechanistic insights into how pre-loading with free cholesterol modulates Mφ ... ...

    Abstract Lipid accumulation in macrophages (Mφs) is a hallmark of atherosclerosis. Yet, how lipid loading modulates Mφ inflammatory responses remains unclear. We endeavored to gain mechanistic insights into how pre-loading with free cholesterol modulates Mφ metabolism upon LPS-induced TLR4 signaling. We found that activities of prolyl hydroxylases (PHDs) and factor inhibiting HIF (FIH) are higher in cholesterol loaded Mφs post-LPS stimulation, resulting in impaired HIF-1α stability, transactivation capacity and glycolysis. In RAW264.7 cells expressing mutated HIF-1α proteins resistant to PHDs and FIH activities, cholesterol loading failed to suppress HIF-1α function. Cholesterol accumulation induced oxidative stress that enhanced NRF2 protein stability and triggered a NRF2-mediated antioxidative response prior to and in conjunction with LPS stimulation. LPS stimulation increased NRF2 mRNA and protein expression, but it did not enhance NRF2 protein stability further. NRF2 deficiency in Mφs alleviated the inhibitory effects of cholesterol loading on HIF-1α function. Mutated KEAP1 proteins defective in redox sensing expressed in RAW264.7 cells partially reversed the effects of cholesterol loading on NRF2 activation. Collectively, we showed that cholesterol accumulation in Mφs induces oxidative stress and NRF2 stabilization, which when combined with LPS-induced NRF2 expression leads to enhanced NRF2-mediated transcription that ultimately impairs HIF-1α-dependent glycolytic and inflammatory responses.
    MeSH term(s) NF-E2-Related Factor 2/metabolism ; NF-E2-Related Factor 2/genetics ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Animals ; Lipopolysaccharides ; Mice ; Macrophages/metabolism ; Macrophages/drug effects ; Macrophages/immunology ; Cholesterol/metabolism ; RAW 264.7 Cells ; Signal Transduction/drug effects ; Oxidative Stress/drug effects ; Kelch-Like ECH-Associated Protein 1/metabolism ; Kelch-Like ECH-Associated Protein 1/genetics ; Up-Regulation/drug effects ; Toll-Like Receptor 4/metabolism
    Language English
    Publishing date 2024-05-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-024-61493-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: The Immune Landscape of Visceral Adipose Tissue During Obesity and Aging.

    Khan, Saad / Chan, Yi Tao / Revelo, Xavier S / Winer, Daniel A

    Frontiers in endocrinology

    2020  Volume 11, Page(s) 267

    Abstract: Obesity and aging represent major health burdens to the global adult population. Both conditions promote the development of associated metabolic diseases such as insulin resistance. The visceral adipose tissue (VAT) is a site that becomes dysfunctional ... ...

    Abstract Obesity and aging represent major health burdens to the global adult population. Both conditions promote the development of associated metabolic diseases such as insulin resistance. The visceral adipose tissue (VAT) is a site that becomes dysfunctional during obesity and aging, and plays a significant role during their pathophysiology. The changes in obese and aging VAT are now recognized to be partly driven by a chronic local inflammatory state, characterized by immune cells that typically adopt an inflammatory phenotype during metabolic disease. Here, we summarize the current knowledge on the immune cell landscape of the VAT during lean, obese, and aged conditions, highlighting their similarities and differences. We also briefly discuss possible linked mechanisms that fuel obesity- and age-associated VAT dysfunction.
    MeSH term(s) Aging/immunology ; Aging/metabolism ; Aging/pathology ; Animals ; Humans ; Intra-Abdominal Fat/immunology ; Intra-Abdominal Fat/metabolism ; Obesity/immunology ; Obesity/metabolism ; Obesity/pathology
    Language English
    Publishing date 2020-05-15
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2020.00267
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top